M. Ono and S. Hakomori, Glycosylation defining cancer cell motility and invasiveness, Glycoconjugate Journal, vol.20, issue.1, pp.71-78, 2004.
DOI : 10.1023/B:GLYC.0000018019.22070.7d

K. Newton and V. Dixit, Signaling in Innate Immunity and Inflammation, Cold Spring Harbor Perspectives in Biology, vol.4, issue.3, p.6049, 2012.
DOI : 10.1101/cshperspect.a006049

J. Petersen, A. Purcell, and J. Rossjohn, Posttranslationally modified T cell epitopes: immune recognition and immunotherapy

N. Rambaruth and M. Dwek, Cell surface glycan???lectin interactions in tumor metastasis, Acta Histochemica, vol.113, issue.6, pp.591-600, 2011.
DOI : 10.1016/j.acthis.2011.03.001

T. Freire, S. Bay, S. Vichier-guerre, R. Lo-man, and C. Leclerc, Carbohydrate Antigens: Synthesis Aspects and Immunological Applications in Cancer, Mini-Reviews in Medicinal Chemistry, vol.6, issue.12, pp.1357-1373, 2006.
DOI : 10.2174/138955706778992996

URL : https://hal.archives-ouvertes.fr/pasteur-00166622

M. Granovsky, J. Fata, and J. Pawling, Suppression of tumor growth and metastasis in Mgat5-deficient mice, Nat. Med, vol.6, pp.306-312, 2000.

P. Bos, X. Zhang, and C. Nadal, Genes that mediate breast cancer metastasis to the brain, Nature, vol.6, issue.7249, pp.1005-1009, 2009.
DOI : 10.1038/nature08021

Y. Matsumoto, Q. Zhang, and K. Akita, pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen, Biochemical and Biophysical Research Communications, vol.419, issue.1, pp.7-13, 2012.
DOI : 10.1016/j.bbrc.2012.01.086

K. Lau and J. Dennis, N-Glycans in cancer progression future science group Review Freire & Osinaga postoperative survival in non-small cell lung cancer, Glycobiology Ann. Thorac. Surg, vol.18, issue.665, pp.750-760, 1998.

B. Yin, C. Finstad, and K. Kitamura, Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer, International Journal of Cancer, vol.261, issue.12, pp.406-412, 1996.
DOI : 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.0.CO;2-0

T. Bogenrieder and M. Herlyn, Axis of evil: molecular mechanisms of cancer metastasis, Oncogene, vol.22, issue.42, pp.6524-6536, 2003.
DOI : 10.1038/sj.onc.1206757

O. Suzuki, Y. Nozawa, and M. Abe, The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1, International Journal of Oncology, vol.28, issue.1, pp.155-160, 2006.
DOI : 10.3892/ijo.28.1.155

I. Brockhausen, Glycodynamics of Mucin Biosynthesis in Gastrointestinal Tumor Cells
DOI : 10.1007/978-1-4615-0065-0_11

S. Hakomori, Tumor-Associated Carbohydrate Antigens Defining Tumor Malignancy: Basis for Development of Anti-Cancer Vaccines, Adv. Exp. Med. Biol, vol.491, pp.369-402, 2001.
DOI : 10.1007/978-1-4615-1267-7_24

S. Itzkowitz, E. Bloom, and W. Kokal, Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients, Cancer, vol.264, issue.9, pp.1960-1966, 1990.
DOI : 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X

S. Itzkowitz, M. Yuan, and C. Montgomery, Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer, Cancer Res, vol.49, issue.1, pp.197-204, 1989.

N. Langkilde, H. Wolf, H. Clausen, T. Kjeldsen, and T. Orntoft, Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression, Cancer, vol.178, issue.1, pp.219-227, 1992.
DOI : 10.1002/1097-0142(19920101)69:1<219::AID-CNCR2820690136>3.0.CO;2-A

N. Langkilde, H. Wolf, H. Clausen, and T. Orntoft, Localization and identification of T-(Gal beta 1?3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer, J. Urol, vol.148, issue.4, pp.1279-1284, 1992.

T. Muramatsu, Carbohydrate signals in metastasis and prognosis of human carcinomas, Glycobiology, vol.3, issue.4, pp.291-296, 1993.
DOI : 10.1093/glycob/3.4.291

Y. Cao, P. Stosiek, G. Springer, and K. U. , Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study, Histochemistry and Cell Biology, vol.213, issue.Suppl 27, pp.197-207, 1996.
DOI : 10.1007/BF02484401

G. T. Springer and . Tn, T and Tn, general carcinoma autoantigens, Science, vol.224, issue.4654, pp.1198-1206, 1984.
DOI : 10.1126/science.6729450

M. Fuster and J. Esko, The sweet and sour of cancer: glycans as novel therapeutic targets, Nature Reviews Cancer, vol.532, issue.7, pp.526-542, 2005.
DOI : 10.1016/S0300-9084(99)80131-X

G. Nores, T. Dohi, M. Taniguchi, and S. Hakomori, Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen, J. Immunol, vol.139, issue.9, pp.3171-3176, 1987.

S. Birks, J. Danquah, and L. King, Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma, Neuro-Oncology, vol.13, issue.9, pp.950-960, 2011.
DOI : 10.1093/neuonc/nor108

F. Brezicka, S. Olling, and O. Nilsson, Immunohistological detection of fucosyl- GM1 ganglioside in human lung cancer and normal tissues with monoclonal antibodies, Cancer Res, vol.49, issue.5, pp.1300-1305, 1989.

O. Nilsson, F. Brezicka, and J. Holmgren, Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1, Cancer Res, vol.46, issue.3, pp.1403-1407, 1986.

A. Vangsted, H. Clausen, and T. Kjeldsen, Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum, Cancer Res, vol.51, issue.11, pp.2879-2884, 1991.

S. Zhang, H. Zhang, and V. Reuter, Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers, Clin. Cancer Res, vol.4, issue.2, pp.295-302, 1998.

M. Li, L. Song, and X. Qin, Glycan changes: cancer metastasis and anti-cancer vaccines, Journal of Biosciences, vol.51, issue.Suppl.1, pp.665-673, 2010.
DOI : 10.1007/s12038-010-0073-8

G. Dunn, A. Bruce, H. Ikeda, L. Old, and R. Schreiber, Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, issue.11, pp.991-998, 2002.
DOI : 10.1038/ni1102-991

M. Vesely, M. Kershaw, R. Schreiber, and M. Smyth, Natural Innate and Adaptive Immunity to Cancer, Annual Review of Immunology, vol.29, issue.1, pp.235-271, 2011.
DOI : 10.1146/annurev-immunol-031210-101324

R. Schreiber, L. Old, and M. Smyth, Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion, Science, vol.331, issue.6024, pp.1565-1570, 2011.
DOI : 10.1126/science.1203486

S. 36-ostrand-rosenberg, P. Sinha, D. Beury, and V. Clements, Cross-talk between myeloidderived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression, Semin. Cancer Biol, 2012.

W. Fridman, B. Mlecnik, G. Bindea, F. Pagès, and J. Galon, Immunosurveillance in human non-viral cancers, Current Opinion in Immunology, vol.23, issue.2, pp.272-278, 2011.
DOI : 10.1016/j.coi.2010.12.011

S. Quezada, K. Peggs, T. Simpson, and A. J. , Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication, Immunological Reviews, vol.205, issue.1, pp.104-118, 2011.
DOI : 10.1111/j.1600-065X.2011.01007.x

J. Wesseling, V. D. Valk, S. Hilkens, and J. , A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1., Molecular Biology of the Cell, vol.7, issue.4, pp.565-577, 1996.
DOI : 10.1091/mbc.7.4.565

V. Glinsky, G. Glinsky, and O. Glinskii, Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium, Urologic Oncology: Seminars and Original Investigations, vol.22, issue.1, pp.3805-3811, 2003.
DOI : 10.1016/j.urolonc.2003.12.009

S. Pinho, M. N. Ferreira, and B. , Biological significance of cancer-associated sialyl-Tn antigen: Modulation of malignant phenotype in gastric carcinoma cells, Cancer Letters, vol.249, issue.2, pp.157-170, 2007.
DOI : 10.1016/j.canlet.2006.08.010

URL : https://hal.archives-ouvertes.fr/hal-00164921

C. Carlos, H. Dong, and O. Howard, Human Tumor Antigen MUC1 Is Chemotactic for Immature Dendritic Cells and Elicits Maturation but Does Not Promote Th1 Type Immunity, The Journal of Immunology, vol.175, issue.3
DOI : 10.4049/jimmunol.175.3.1628

N. Yokoigawa, N. Takeuchi, and M. Toda, Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream, Cancer Letters, vol.245, issue.1-2, pp.149-155, 2007.
DOI : 10.1016/j.canlet.2006.01.004

I. Sugihara, M. Yoshida, and T. Shigenobu, Different Progression of Tumor Xenografts between Mucin-Producing and Mucin-Non-Producing Mammary Adenocarcinoma-Bearing Mice, Cancer Research, vol.66, issue.12, pp.6175-6182, 2006.
DOI : 10.1158/0008-5472.CAN-05-3663

A. Varki, Selectin ligands: will the real ones please stand up?, Journal of Clinical Investigation, vol.99, issue.2, pp.158-162, 1997.
DOI : 10.1172/JCI119142

S. Portela, C. Martín, and L. Romay, sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis, Histol. Histopathol, vol.26, issue.10, pp.1305-1316, 2011.

A. Cazet, S. Julien, and M. Bobowski, Consequences of the expression of sialylated antigens in breast cancer, Carbohydrate Research, vol.345, issue.10, pp.1377-1383, 1994.
DOI : 10.1016/j.carres.2010.01.024

URL : https://hal.archives-ouvertes.fr/hal-00464837

L. Durrant, V. Pudney, and I. Spendlove, Using monoclonal antibodies to stimulate antitumor cellular immunity, Expert Review of Vaccines, vol.10, issue.7, pp.1093-1106, 2011.
DOI : 10.1586/erv.11.33

J. Kirkwood, R. Mascari, and H. Edington, Analysis of therapeutic and immunologic effects of R24 anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma, Cancer, vol.97, issue.12, pp.2693-2702, 2000.
DOI : 10.1002/1097-0142(20000615)88:12<2693::AID-CNCR7>3.0.CO;2-3

M. Retter, J. Johnson, and D. Peckham, Characterization of a Proapoptotic Antiganglioside GM2 Monoclonal Antibody and Evaluation of Its Therapeutic Effect on Melanoma and Small Cell Lung Carcinoma Xenografts, Cancer Research, vol.65, issue.14, pp.6425-6434, 2005.
DOI : 10.1158/0008-5472.CAN-05-0300

N. 109-alvarez-rueda, S. Leprieur, and B. Clémenceau, Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen, Clinical Cancer Research, vol.13, issue.18, pp.5613-5620, 2007.
DOI : 10.1158/1078-0432.CCR-07-1057

K. Kitamura, E. Stockert, and P. Garin-chesa, Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants., Proc. Natl Acad. Sci. USA. 91, pp.12957-12961, 1994.
DOI : 10.1073/pnas.91.26.12957

R. Sawada, S. Sun, and X. Wu, Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity, Clinical Cancer Research, vol.17, issue.5, pp.1024-1032, 2011.
DOI : 10.1158/1078-0432.CCR-10-2640

L. Durrant, P. Noble, and I. Spendlove, Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy, Clinical & Experimental Immunology, vol.99, issue.1, pp.206-215, 2012.
DOI : 10.1111/j.1365-2249.2011.04516.x

J. Gubbels, B. Gadbaw, and I. Buhtoiarov, Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface, Cancer Immunology, Immunotherapy, vol.21, issue.12, pp.1789-1800, 2011.
DOI : 10.1007/s00262-011-1072-9

M. 114-sadelain, I. Riviere, and R. Brentjens, Targeting tumours with genetically enhanced T lymphocytes, Nature Reviews Cancer, vol.3, issue.1, pp.35-45, 2003.
DOI : 10.1038/nrc971

C. 115-ramos and D. G. , Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy, Expert Opinion on Biological Therapy, vol.2, issue.2, pp.855-873, 2011.
DOI : 10.1073/pnas.092562399

C. Rossig, C. Bollard, J. Nuchtern, D. Merchant, and M. Brenner, Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes, International Journal of Cancer, vol.96, issue.2, pp.228-236, 2001.
DOI : 10.1002/ijc.1457

C. Yun, K. Nolan, E. Beecham, R. Reisfeld, and R. Junghans, Targeting of T Lymphocytes to Melanoma Cells Through Chimeric Anti-GD3 Immunoglobulin T-Cell Receptors, Neoplasia, vol.2, issue.5, pp.449-459, 2000.
DOI : 10.1038/sj.neo.7900108

E. 118-yvon, D. Vecchio, M. Savoldo, and B. , Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells, Clinical Cancer Research, vol.15, issue.18, pp.5852-5860, 2009.
DOI : 10.1158/1078-0432.CCR-08-3163

A. Lo, Q. Ma, D. Liu, and R. Junghans, Anti-GD3 Chimeric sFv-CD28/T-Cell Receptor ?? Designer T Cells for Treatment of Metastatic Melanoma and Other Neuroectodermal Tumors, Clinical Cancer Research, vol.16, issue.10, pp.2769-2780, 2010.
DOI : 10.1158/1078-0432.CCR-10-0043

J. Westwood, M. Smyth, and M. Teng, Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice, Proc. Natl Acad. Sci. USA, pp.19051-19056, 2005.
DOI : 10.1073/pnas.0504312102

S. Wilkie, G. Picco, and J. Foster, Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor, The Journal of Immunology, vol.180, issue.7, pp.4901-4909, 2008.
DOI : 10.4049/jimmunol.180.7.4901

J. Maher and S. Wilkie, CAR Mechanics: Driving T Cells into the MUC of Cancer, Cancer Research, vol.69, issue.11, pp.4559-4562, 2009.
DOI : 10.1158/0008-5472.CAN-09-0564

S. Wilkie, S. Burbridge, and L. Chiapero-stanke, Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4, Journal of Biological Chemistry, vol.285, issue.33, pp.25538-25544, 2010.
DOI : 10.1074/jbc.M110.127951

M. Cartellieri, M. Bachmann, and A. Feldmann, Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer, Journal of Biomedicine and Biotechnology, vol.21, issue.4
DOI : 10.1038/nm.1882

F. Helling and P. Livingston, Ganglioside conjugate vaccines Immunotherapy against tumors of neuroectodermal origin, Mol. Chem. Neuropathol, vol.2123, pp.299-309, 1994.

E. 126-kagan, G. Ragupathi, and S. Yi, Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn, Cancer Immunology, Immunotherapy, vol.263, issue.5, pp.424-430, 2005.
DOI : 10.1007/s00262-004-0584-y

V. Kudryashov, H. Kim, and G. Ragupathi, Immunogenicity of synthetic conjugates of Lewis y oligosaccharide with proteins in mice: towards the design of anticancer vaccines, Cancer Immunology, Immunotherapy, vol.45, issue.6, pp.281-286, 1998.
DOI : 10.1007/s002620050444

Z. Guo and Q. Wang, Recent development in carbohydrate-based cancer vaccines, Current Opinion in Chemical Biology, vol.13, issue.5-6, pp.5-6, 2009.
DOI : 10.1016/j.cbpa.2009.08.010

S. Bay, S. Fort, and L. Birikaki, Induction of a Melanoma-Specific Antibody Response by a Monovalent, but not a Divalent, Synthetic GM2 Neoglycopeptide, ChemMedChem, vol.6, issue.4, pp.582-587, 2009.
DOI : 10.1002/cmdc.200900032

URL : https://hal.archives-ouvertes.fr/hal-00396633

P. Fung, M. Madej, R. Koganty, and B. Longenecker, Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate, Cancer Res, vol.50, issue.14, pp.4308-4314, 1990.

S. Grigalevicius, S. Chierici, and O. Renaudet, Chemoselective Assembly and Immunological Evaluation of Multiepitopic Glycoconjugates Bearing Clustered Tn Antigen as Synthetic Anticancer Vaccines, Bioconjugate Chemistry, vol.16, issue.5, pp.1149-1159, 2005.
DOI : 10.1021/bc050010v

V. Kudryashov, P. Glunz, and L. Williams, Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewisy conjugates in mice, Proc. Natl Acad. Sci. USA 98, pp.3264-3269, 2001.
DOI : 10.1073/pnas.051623598

R. Lo-man, S. Vichier-guerre, and E. Dériaud, Anti-Tumor Immunity Provided by a Synthetic Multiple Antigenic Glycopeptide Displaying a Tri-Tn Glycotope, The Journal of Immunology, vol.166, issue.4, pp.2849-2854, 2001.
DOI : 10.4049/jimmunol.166.4.2849

URL : https://hal.archives-ouvertes.fr/pasteur-00166855

R. Lo-man, S. Vichier-guerre, and R. Perraut, A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates, Cancer Research, vol.64, issue.14, pp.4987-4994, 2004.
DOI : 10.1158/0008-5472.CAN-04-0252

URL : https://hal.archives-ouvertes.fr/pasteur-00166848

B. Longenecker, M. Reddish, R. Koganty, and G. Maclean, Immune Responses of Mice and Human Breast Cancer Patients following Immunization with Synthetic Sialyl-Tn Conjugated to KLH Plus Detox Adjuvant, Annals of the New York Academy of Sciences, vol.51, issue.1 Specific Immu, pp.276-291, 1993.
DOI : 10.1073/pnas.87.23.9498

B. Longenecker, M. Reddish, R. Koganty, and G. Maclean, Specificity of the IgG Response in Mice and Human Breast Cancer Patients Following Immunization Against Synthetic Sialyl-Tn, An Epitope with Possible Functional Significance in Metastasis, Adv. Exp. Med. Biol, vol.353, pp.105-124, 1994.
DOI : 10.1007/978-1-4615-2443-4_11

G. Ragupathi, S. Cappello, and S. Yi, Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines, Vaccine, vol.20, issue.7-8, pp.1030-1038, 2002.
DOI : 10.1016/S0264-410X(01)00451-0

T. Toyokuni, S. Hakomori, and A. Singhal, Synthetic carbohydrate vaccines: Synthesis and immunogenicity of Tn antigen conjugates, Bioorganic & Medicinal Chemistry, vol.2, issue.11, pp.1119-1132, 1994.
DOI : 10.1016/S0968-0896(00)82064-7

P. Chapman, D. Wu, and G. Ragupathi, Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside, Clinical Cancer Research, vol.10, issue.14, pp.4717-4723, 2004.
DOI : 10.1158/1078-0432.CCR-04-0345

G. Maclean, M. Reddish, and R. Koganty, Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant, Cancer Immunology Immunotherapy, vol.12, issue.4, pp.215-222, 1993.
DOI : 10.1007/BF01740902

S. Slovin, S. Keding, and G. Ragupathi, Carbohydrate vaccines as immunotherapy for cancer, Immunology and Cell Biology, vol.22, issue.4, pp.418-428, 2005.
DOI : 10.1016/j.vaccine.2005.01.072

S. Vichier-guerre, R. Lo-man, and S. Bay, Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen, Journal of Peptide Research, vol.9, issue.2, pp.173-180, 2000.
DOI : 10.1023/A:1006939432665

URL : https://hal.archives-ouvertes.fr/pasteur-00166856

E. Osinaga, S. Bay, and D. Tello, Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy, FEBS Letters, vol.412, issue.1, pp.24-28, 2000.
DOI : 10.1016/S0014-5793(00)01248-5

URL : https://hal.archives-ouvertes.fr/pasteur-00166863

U. Karsten, C. Diotel, and G. Klich, Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation, Cancer Res, vol.58, issue.12, pp.2541-2549, 1998.

U. Karsten, V. Mensdorff-pouilly, S. Goletz, and S. , What Makes MUC1 a Tumor Antigen?, Tumor Biology, vol.155, issue.4, pp.217-220, 2005.
DOI : 10.1159/000070658

V. Mensdorff-pouilly, S. Petrakou, E. Kenemans, and P. , Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides, Int. J. Cancer, vol.86, issue.5, pp.702-712, 2000.

V. Mensdorff-pouilly, S. Kinarsky, L. Engelmann, and K. , Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses, Glycobiology, vol.15, issue.8, pp.735-746, 2005.
DOI : 10.1093/glycob/cwi058

S. Ryan, A. Vlad, K. Islam, J. Gariépy, and O. Finn, Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice, Biological Chemistry, vol.390, issue.7, pp.611-618, 2009.
DOI : 10.1515/BC.2009.070

J. Zhu, Q. Wan, and D. Lee, From Synthesis to Biologics: Preclinical Data on a Chemistry Derived Anticancer Vaccine, Journal of the American Chemical Society, vol.131, issue.26, pp.9298-9303, 2009.
DOI : 10.1021/ja901415s

M. Tarp and H. Clausen, Mucin-type O-glycosylation and its potential use in drug and vaccine development, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1780, issue.3, pp.546-563, 2008.
DOI : 10.1016/j.bbagen.2007.09.010

F. Corzana, J. Busto, G. De-luis, and M. , The nature and sequence of the amino acid aglycone strongly modulates the conformation and dynamics effects of Tn antigen's clusters future science group Review Freire & Osinaga 153 Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21, Chemistry Clin. Cancer Res, vol.15, issue.9, pp.3863-3874, 2003.

Y. 154-pan, P. Chefalo, N. Nagy, C. Harding, and Z. Guo, Synthesis and Immunological Properties of N-Modified GM3 Antigens as Therapeutic Cancer Vaccines, Journal of Medicinal Chemistry, vol.48, issue.3, pp.875-883, 2005.
DOI : 10.1021/jm0494422

D. Liu, D. Song, and G. Guo, The synthesis of 18??-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells, Bioorganic & Medicinal Chemistry, vol.15, issue.16, pp.5432-5439, 2007.
DOI : 10.1016/j.bmc.2007.05.057

D. Dudziak, A. Kamphorst, and G. Heidkamp, Differential Antigen Processing by Dendritic Cell Subsets in Vivo, Science, vol.315, issue.5808, pp.107-111, 2007.
DOI : 10.1126/science.1136080

E. Klechevsky, R. Morita, and M. Liu, Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells, Immunity, vol.29, issue.3, pp.497-510, 2008.
DOI : 10.1016/j.immuni.2008.07.013

T. Geijtenbeek and S. Gringhuis, Signalling through C-type lectin receptors: shaping immune responses, Nature Reviews Immunology, vol.16, issue.7, pp.465-479, 2009.
DOI : 10.1038/nri2569

S. Singh, I. Streng-ouwehand, and M. Litjens, Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization, European Journal of Immunology, vol.223, issue.4, pp.916-925, 2011.
DOI : 10.1002/eji.201040762

V. Karanikas, G. Thynne, and P. Mitchell, Mannan Mucin-1 Peptide Immunization: Influence of Cyclophosphamide and the Route of Injection, Journal of Immunotherapy, vol.24, issue.2, pp.172-183, 2001.
DOI : 10.1097/00002371-200103000-00012

G. Springer, Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy, Journal of Molecular Medicine, vol.75, issue.8, pp.594-602, 1997.
DOI : 10.1007/s001090050144

G. Springer, P. Desai, H. Tegtmeyer, S. Carlstedt, and E. Scanlon, T/Tn Antigen Vaccine is Effective and Safe in Preventing Recurrence of Advanced Human Breast Carcinoma, Cancer Biotherapy, vol.9, issue.1, pp.7-15, 1994.
DOI : 10.1089/cbr.1994.9.7

O. Finn, Cancer vaccines: between the idea and the reality, Nature Reviews Immunology, vol.3, issue.8, pp.630-641, 2003.
DOI : 10.1038/nri1150

C. Paula, A. Motta, and C. Schmitz, Alterations in dendritic cell function in aged mice: potential implications for immunotherapy design, Biogerontology, vol.268, issue.1, pp.13-25, 2009.
DOI : 10.1007/s10522-008-9150-x

R. Ortiz, C. Melguizo, and J. Prados, New gene therapy strategies for cancer treatment: a review of recent patents, Recent Pat. Anticancer Drug Discov, 2012.